113 related articles for article (PubMed ID: 23704908)
1. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
[TBL] [Abstract][Full Text] [Related]
2. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
Jiang F; Mu J; Wang X; Ye X; Si L; Ning S; Li Z; Li Y
PLoS One; 2014; 9(5):e96698. PubMed ID: 24806207
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma.
Zhang C; Wei W; Tu S; Liang B; Li C; Li Y; Luo W; Wu Y; Dai X; Wang Y; Zheng L; Hao L; Zhang C; Luo Z; Chen YG; Yan X
J Biol Chem; 2024 Apr; 300(4):107208. PubMed ID: 38521502
[TBL] [Abstract][Full Text] [Related]
4. IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.
Liu C; Billadeau DD; Abdelhakim H; Leof E; Kaibuchi K; Bernabeu C; Bloom GS; Yang L; Boardman L; Shah VH; Kang N
J Clin Invest; 2013 Mar; 123(3):1138-56. PubMed ID: 23454766
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta.
Rojas A; Padidam M; Cress D; Grady WM
Biochim Biophys Acta; 2009 Jul; 1793(7):1165-73. PubMed ID: 19339207
[TBL] [Abstract][Full Text] [Related]
6. Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes.
Xu Y; Baker D; Quan T; Baldassare JJ; Voorhees JJ; Fisher GJ
Mol Biol Cell; 2010 Jan; 21(1):29-35. PubMed ID: 19864455
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
Chen J; Zaidi S; Rao S; Chen JS; Phan L; Farci P; Su X; Shetty K; White J; Zamboni F; Wu X; Rashid A; Pattabiraman N; Mazumder R; Horvath A; Wu RC; Li S; Xiao C; Deng CX; Wheeler DA; Mishra B; Akbani R; Mishra L
Gastroenterology; 2018 Jan; 154(1):195-210. PubMed ID: 28918914
[TBL] [Abstract][Full Text] [Related]
9. Liebig's law of the minimum in the TGF-β/SMAD pathway.
Li Y; Deng D; Höfer CT; Kim J; Do Heo W; Xu Q; Liu X; Zi Z
PLoS Comput Biol; 2024 May; 20(5):e1012072. PubMed ID: 38753874
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
Otegbeye F; Ojo E; Moreton S; Mackowski N; Lee DA; de Lima M; Wald DN
PLoS One; 2018; 13(1):e0191358. PubMed ID: 29342200
[TBL] [Abstract][Full Text] [Related]
11. TGFβR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll-like-receptor signalling.
Mohamed FEZA; Dewidar B; Lin T; Ebert MP; Dooley S; Meindl-Beinker NM; Hammad S
Int J Exp Pathol; 2024 Apr; 105(2):64-74. PubMed ID: 38328944
[TBL] [Abstract][Full Text] [Related]
12. Chimeric TβRII-SE/Fc overexpression by a lentiviral vector exerts strong antitumoral activity on colorectal cancer-derived cell lines in vitro and on xenografts.
Romo A; Rodríguez TM; Yu G; Dewey RA
Cancer Gene Ther; 2024 Jan; 31(1):174-185. PubMed ID: 37993543
[TBL] [Abstract][Full Text] [Related]
13. TGF-β signaling pathway mediated by deubiquitinating enzymes.
Kim SY; Baek KH
Cell Mol Life Sci; 2019 Feb; 76(4):653-665. PubMed ID: 30349992
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of sorafenib and lenvatinib on HepG2 cells and human umbilical vein endothelial cells: Involvement of transforming growth factor-β signaling in their molecular effects.
Wang T; Takikawa Y; Suzuki K; Kuroda H; Kakisaka K; Chiba T
Hepatol Res; 2024 Apr; ():. PubMed ID: 38666637
[TBL] [Abstract][Full Text] [Related]
15. Tgf-Beta superfamily receptors-targets for antiangiogenic therapy?
Otten J; Bokemeyer C; Fiedler W
J Oncol; 2010; 2010():317068. PubMed ID: 20490264
[TBL] [Abstract][Full Text] [Related]
16. Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation.
Steinway SN; Zañudo JG; Ding W; Rountree CB; Feith DJ; Loughran TP; Albert R
Cancer Res; 2014 Nov; 74(21):5963-77. PubMed ID: 25189528
[TBL] [Abstract][Full Text] [Related]
17. The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications.
Gungor MZ; Uysal M; Senturk S
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205692
[TBL] [Abstract][Full Text] [Related]
18. Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression.
Wang H; Wang P; Xu M; Song X; Wu H; Evert M; Calvisi DF; Zeng Y; Chen X
Cell Death Dis; 2021 Feb; 12(2):200. PubMed ID: 33608500
[TBL] [Abstract][Full Text] [Related]
19. Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness.
Ning J; Ye Y; Bu D; Zhao G; Song T; Liu P; Yu W; Wang H; Li H; Ren X; Ying G; Zhao Y; Yu J
Mol Ther; 2021 Jun; 29(6):2067-2087. PubMed ID: 33601054
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.
Liu Y; Wang M; Luo Y; Chen J; Lu Y; Shi Y; Tang C; Zhou Q; Zhang H; Hu Y; Su S; Chen Q
Sci Rep; 2017 Sep; 7(1):11054. PubMed ID: 28887510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
